SCHEMBL7559605

SCHEMBL7559605

C=CCc1ccc(N)c2c(=O)c(C(=O)O)c[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 5/20 0.43
▸ CSNK2A2 P19784 4/20 0.43
▸ CSNK2B P67870 4/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ CASP6 P55212 2/20 0.34
▸ DNA2 P51530 1/20 0.34
▸ CTDSP1 Q9GZU7 1/20 0.34
▸ PIM3 Q86V86 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ TET2 Q6N021 1/20 0.33
▸ TET1 Q8NFU7 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ MDH2 P40926 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CDC25B P30305 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7552991 0.81 CASP6 (0.50) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL7556910 0.76 CSNK2A2 (0.55) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL7515189 0.75 CYP1A2 (0.49) CSNK2A1CSNK2A2CSNK2BCYP1A2HSD17B10
SCHEMBL7594871 0.67 CASP6 (0.39) CYP1A2KDM4EALDH1A1CASP6CDC25B
SCHEMBL8055510 0.65 ALDH1A1 (0.41) ALDH1A1
SCHEMBL1081402 0.65 KDM4E (0.47) HSD17B10KDM4EALDH1A1HPGDHTT
SCHEMBL2852455 0.65 ALDH1A1 (0.53) CYP1A2HSD17B10KDM4EALDH1A1HPGD
SCHEMBL5238370 0.64 KDM4E (0.46) CYP1A2HSD17B10KDM4EALDH1A1HPGD
SCHEMBL9081528 0.64 IDO1 (0.42) HSD17B10KDM4EALDH1A1HPGDCASP6
SCHEMBL27615088 0.64 ALDH1A1 (0.41) CYP1A2HSD17B10KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof DAIICHI PHARMACEUTICAL CO., LTD. 2002-12-19 — — US disclosed
EP-1167344-A1 PROCESS FOR PRODUCING 5-AMINO-8- ALKYLQUINOLO NECARBOXYLIC ACID DERIVATIVES AND INTERMEDIATES IN THE PRODUCTION THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof SQOR, XDH, SPOUT1 CSNK2A1 1882/4885CSNK2A2 2090/4885CSNK2B 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback